ARCHIVES

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009

Scientists Glimpse Cellular Machines Inside Living Cells; Funding Opportunities

November 22, 2002

Scientists Tell Panel: Peer Review Need Improving, Available Funds Should Be Spread Over More Grants

April 30, 1982

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

December 18, 1998

Group Urges Journals To Run Corrections For I-ELCAP Papers.

January 25, 2008

New RFAs on Retinoids & Carotenoids, Tobacco, NMR Research Resistance

July 27, 1984